Patrizia Lorenzini
Overview
Explore the profile of Patrizia Lorenzini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasquale L, Grande G, Zagari R, Biancheri P, Pisani A, Da Massa Carrara P, et al.
Endosc Int Open
. 2025 Feb;
13:a25158539.
PMID: 40007647
Background And Study Aims: Despite lower patient adherence, the overnight split-dose (SD) intestinal preparation regimen is currently recommended for early morning colonoscopies. Using low-volume preparation, we compared performance of a...
2.
Vaccaro R, Lorenzini P, Giaquinto F, Matascioli F, Carnevale G, Sciancalepore F, et al.
Aging Clin Exp Res
. 2024 Dec;
37(1):1.
PMID: 39704981
Background: The Italian Fund for Alzheimer's and other dementias approved in 2020 enabled the conducting of a survey in the Italian Centers for Cognitive Disorders and Dementias (CCDDs) to analyse...
3.
Vergori A, Del Duca G, Lorenzini P, Brita A, Mastrorosa I, Fusto M, et al.
AIDS
. 2024 Oct;
39(3):270-275.
PMID: 39453875
Objectives: The aim was to investigate whether switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/F/TDF) to bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) may improve neuropsychiatric symptoms and neurocognition. Design: Pilot, single-arm, prospective study of persons...
4.
Pilotto A, Barbagelata M, Lacorte E, Custodero C, Veronese N, Maione V, et al.
Trials
. 2024 Sep;
25(1):611.
PMID: 39272196
Background: Multicomponent interventions based on a comprehensive geriatric assessment (CGA) could promote active aging and improve health status in older people with Noncommunicable Chronic Diseases (NCDs), but conflicting evidences are...
5.
Giaquinto F, Lorenzini P, Salvi E, Carnevale G, Vaccaro R, Matascioli F, et al.
J Alzheimers Dis
. 2024 Aug;
101(2):509-524.
PMID: 39213073
Background: The wait for the upcoming disease-modifying therapies (DMT) for Alzheimer's disease in Europe is raising questions about the preparedness of national healthcare systems to conduct accurate diagnoses and effective...
6.
Lombardo F, Lorenzini P, Mayer F, Massari M, Piscopo P, Bacigalupo I, et al.
Diagn Progn Res
. 2024 Jul;
8(1):11.
PMID: 39049042
Background: In recent years, significant efforts have been directed towards the research and development of disease-modifying therapies for dementia. These drugs focus on prodromal (mild cognitive impairment, MCI) and/or early...
7.
Bacigalupo I, Giaquinto F, Salvi E, Carnevale G, Vaccaro R, Matascioli F, et al.
Neurol Sci
. 2023 Aug;
45(2):525-538.
PMID: 37592124
Introduction: A new national survey has been carried out by the Italian Centers for Cognitive Disorders and Dementias (CCDDs). The aim of this new national survey is to provide a...
8.
Mastrorosa I, Del Duca G, Pinnetti C, Lorenzini P, Vergori A, Brita A, et al.
Health Qual Life Outcomes
. 2023 Mar;
21(1):28.
PMID: 36949439
Background: After the acute phase, symptoms or sequelae related to post-COVID-19 syndrome may persist for months. In a population of patients, previously hospitalized and not, followed up to 12 months...
9.
Mastrorosa I, Gagliardini R, Segala F, Mondi A, Lorenzini P, Cerva C, et al.
EClinicalMedicine
. 2023 Mar;
57:101895.
PMID: 36936403
Background: Among interleukin-6 inhibitors suggested for use in COVID-19, there are few robust evidences for the efficacy of sarilumab. Herein, we evaluated the efficacy and safety of sarilumab in severe...
10.
Gagliardini R, Lorenzini P, Cozzi-Lepri A, Tavelli A, Borghi V, Galli L, et al.
J Glob Antimicrob Resist
. 2022 Nov;
32:158-163.
PMID: 36402369
Background: Dolutegravir (DTG) +lamivudine (3TC) combination has been found to be as effective as triple therapies, and has been extensively prescribed in clinical practice as a maintenance therapy. We aimed...